- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
UPDATED Jun 22, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
959 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
1024 | HK$49.35 | -3.1% | -8.9% | HK$213.8b | HK$79.21 | PE17.5x | E22.7% | n/a | Media | ||
GALD | CHF74.86 | -0.2% | n/a | CHF17.8b | CHF77.85 | PS4.8x | E42.9% | n/a | Pharmaceuticals & Biotech | ||
MUSTI | €25.40 | -0.4% | 41.9% | €848.1m | €24.00 | PE54.3x | E38.5% | 2.4% | Retail | ||
CGY | CA$55.44 | 2.0% | -6.9% | CA$657.4m | CA$78.57 | PE32.5x | E30.7% | 2.0% | Commercial Services | ||
8936 | NT$75.90 | -4.2% | 147.6% | NT$18.8b | NT$73.00 | PE26.3x | E33.5% | 2.0% | Capital Goods | ||
CTH1V | €3.05 | -4.4% | 3.4% | €29.6m | €3.60 | PE19.1x | E45.6% | n/a | Capital Goods | ||
A119610 | ₩24,900.00 | 0% | -31.1% | ₩312.1b | ₩43,250.00 | PE27.1x | E58.4% | 2.4% | Healthcare | ||
USCB | US$11.88 | -1.7% | 10.2% | US$233.5m | US$13.50 | PB1.2x | E25.3% | 1.7% | Banks | ||
EAAS | UK£0.055 | -4.3% | 26.4% | UK£21.3m | n/a | PS1.2x | E91.1% | n/a | Commercial Services | ||
NEXN | UK£2.47 | 0.2% | -9.6% | UK£342.0m | UK£10.00 | PS1.3x | E117.9% | 0% | Media | ||
DIDI.Y | US$4.44 | 4.2% | 60.3% | US$21.5b | US$5.50 | PB1.6x | E149.5% | n/a | Transportation | ||
NE | US$44.47 | 3.4% | 21.8% | US$6.4b | US$58.73 | PE13.5x | E29.9% | 3.6% | Energy | ||
LAB B | Mex$16.72 | 2.3% | 18.0% | Mex$15.8b | Mex$19.50 | PE15.1x | E28.6% | 4.7% | Pharmaceuticals & Biotech | ||
HTRO | kr49.85 | -1.8% | -28.2% | kr10.1b | kr57.33 | PE14.8x | E21.4% | 0% | Capital Goods | ||
CAPMAN | €1.91 | 1.1% | -25.2% | €338.5m | €2.30 | PE95.8x | E35.1% | 5.2% | Diversified Financials | ||
AZT | kr24.55 | -0.2% | -35.1% | kr1.2b | kr27.50 | PE71.1x | E48.5% | n/a | Pharmaceuticals & Biotech | ||
SIGI | US$92.52 | 2.3% | -3.9% | US$5.6b | US$105.71 | PE16.3x | E23.3% | 1.5% | Insurance | ||
2782 | CN¥11.14 | -1.8% | -26.1% | CN¥5.5b | n/a | PE40.3x | E48.5% | 0.7% | Capital Goods | ||
HMSP | Rp695.00 | 2.2% | -25.7% | Rp80.8t | Rp969.17 | PE9.9x | E11.8% | 10.0% | Food, Beverage & Tobacco | ||
HSAI | US$4.22 | -12.3% | -57.7% | US$538.0m | US$10.07 | PS2.2x | E71.0% | n/a | Automobiles | ||
MERC | UK£0.29 | 0% | 15.7% | UK£127.2m | n/a | PS4.4x | E129.2% | 3.0% | Diversified Financials | ||
A372910 | ₩5,430.00 | -4.9% | -17.6% | ₩150.3b | n/a | PE64.5x | E37.9% | n/a | Commercial Services | ||
ALVU | €15.15 | 3.1% | 47.1% | €145.8m | €18.40 | PE15x | E13.7% | 2.8% | Retail | ||
5726 | JP¥2,808.00 | -6.9% | -2.7% | JP¥103.3b | JP¥4,450.00 | PE10.7x | E11.6% | 2.5% | Materials |